An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer (Q40200097)
Jump to navigation
Jump to search
scientific article published on 27 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer |
scientific article published on 27 June 2007 |
Statements
1 reference
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer (English)
1 reference
Marc Salzberg
1 reference
Christoph Rochlitz
1 reference
Rudolf Morant
1 reference
George Thalmann
1 reference
Augusto Pedrazzini
1 reference
Enrico Roggero
1 reference
Astrid Schönenberger
1 reference
Alexander Knuth
1 reference
Markus Borner
1 reference
27 June 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference